PharmEasy

Latest news

1. 12 Oct
   API Holdings cuts FY26 loss 67% to ₹520 crore

   API Holdings, parent of PharmEasy, narrowed its consolidated net loss to ₹520 crore in FY26 from ₹1,572 crore a year earlier, while operating revenue rose 12.7% to ₹6,618.5 crore. The company said margin improvements came from higher‑margin products, private labels, and discount optimisation, though it still reported a loss before tax of ₹456.1 crore.

   Business · 1 source

   

Articles

No articles about PharmEasy yet.